IL4I1 and cancer: Specifically, indole-3-pyruvic acid (I3P) and indole-3-aldehyde (I3A) catalyzed by IL4I1 in tumor activated AHR signaling through receptor-ligand binding, leading to increased motility of cancer cells and diminished proliferation of cytotoxic CD8+ T cells [9].